What are the main effects and possible side effects of rasagiline?
Rasagilineis a monoamine oxidaseB (MAO-B) inhibitor, mainly used for the treatment of Parkinson's disease. It mainly inhibits the activity of monoamine oxidaseB in the brain and delays the decomposition of dopamine, thereby increasing the level of dopamine between neurons and helping to improve the motor symptoms of patients with Parkinson's disease. Rasagiline is usually used as a monotherapy to treat early-stage Parkinson's disease. It can also be used in combination with levodopa, especially to improve the "shuttle" symptoms caused by levodopa and reduce its dosage. The effect of rasagiline is reflected in improving bradykinesia, tremor, stiffness and other symptoms, thereby improving the patient's quality of life.

Although rasagiline's efficacy is widely recognized, its use may still be associated with some side effects. Common side effects include headache, nausea, insomnia, loss of appetite, constipation and other minor symptoms. Additionally, some patients may experience low blood pressure, especially when standing up, resulting in dizziness or syncope. In more severe cases, rasagiline may cause hallucinations or psychotic symptoms, especially in older patients. Patients who take rasagiline for a long time may also develop abnormal liver function, so liver function tests need to be checked regularly.
Rare side effects that require special attention include symptoms such as acute high fever and muscle stiffness, which may be early manifestations of malignant hyperthermia syndrome. If such symptoms occur, the drug should be discontinued immediately and medical help should be sought.
In summary, rasagiline, as a treatment for Parkinson's disease, can effectively improve motor symptoms, but it may also cause a series of side effects, especially gastrointestinal discomfort, nervous system-related problems, and hypotension. When using rasagiline, patients need to reasonably control the dosage and regularly monitor their physical condition under the guidance of a doctor to ensure safety.
Reference materials:https://www.azilect.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)